Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer
Clinical trial NCT01891227 · COMPLETED
Trial details
- NCT number
- NCT01891227
- Sponsor
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-09
- Primary completion
- 2018-03-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.